These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37340250)

  • 41. Assessing the Retail Environments of Licensed and Unlicensed Cannabis Dispensaries: Adapting the Marijuana Retail Surveillance Tool to Inform Cannabis Regulation in Los Angeles County.
    Nicholas W; Washburn F; Lee G; Loprieno D; Greenwell L; Berg C
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):403-411. PubMed ID: 32810068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
    Shi Y; Liang D
    Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
    JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
    Khobrani M; Perona S; Patanwala AE
    Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of pre-hospital cannabis exposure and hospital opioid utilization in a trauma population: A retrospective cohort.
    Chang AJ; Mallat AF; Edwards MJ; Gabra JN; Cucci MD
    Injury; 2024 May; 55(5):111305. PubMed ID: 38216357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Has a Prescription-limiting Law in Rhode Island Helped to Reduce Opioid Use After Total Joint Arthroplasty?
    Reid DBC; Shapiro B; Shah KN; Ruddell JH; Cohen EM; Akelman E; Daniels AH
    Clin Orthop Relat Res; 2020 Feb; 478(2):205-215. PubMed ID: 31389888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recreational cannabis and opioid distribution.
    Raman S; Maclean JC; Bradford WD; Drake C
    Health Econ; 2023 Apr; 32(4):747-754. PubMed ID: 36653623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
    Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
    JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
    Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
    Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado.
    Doremus JM; Stith SS; Vigil JM
    Complement Ther Med; 2019 Dec; 47():102207. PubMed ID: 31779999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
    Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
    Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017.
    Santaella-Tenorio J; Wheeler-Martin K; DiMaggio CJ; Castillo-Carniglia A; Keyes KM; Hasin D; Cerdá M
    JAMA Intern Med; 2020 Aug; 180(8):1061-1068. PubMed ID: 32568378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-World Observational Evaluation of Common Interventions to Reduce Emergency Department Prescribing of Opioid Medications.
    Sangal RB; Rothenberg C; Hawk K; D'Onofrio G; Hsiao AL; Solad Y; Venkatesh AK
    Jt Comm J Qual Patient Saf; 2023 May; 49(5):239-246. PubMed ID: 36914528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marijuana legalization and opioid deaths.
    Mathur NK; Ruhm CJ
    J Health Econ; 2023 Mar; 88():102728. PubMed ID: 36808015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reefer madness or much ado about nothing? Cannabis legalization outcomes among young adults in the United States.
    Parnes JE; Smith JK; Conner BT
    Int J Drug Policy; 2018 Jun; 56():116-120. PubMed ID: 29626630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in Healthcare Encounter Rates Possibly Related to Cannabis or Alcohol following Legalization of Recreational Marijuana in a Safety-Net Hospital: An Interrupted Time Series Analysis.
    Calcaterra SL; Hopfer CJ; Keniston A; Hull ML
    J Addict Med; 2019; 13(3):201-208. PubMed ID: 30475257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.